ALC Stock: Price, Earnings History and SEC Filings
Alcon Inc. (ALC) last traded at $71.45, up 0.45% on the latest session and up 10.3% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.84 against an analyst estimate of $0.77, a beat of 9.1%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ALC earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 10, 2026 | $0.84 | $0.77 | +9.09% |
| Mar 2026 | May 5, 2026 | $0.85 | $0.80 | +6.25% |
| Dec 2025 | Feb 24, 2026 | $0.78 | $0.79 | -1.27% |
| Sep 2025 | Nov 11, 2025 | $0.79 | $0.77 | +2.60% |
ALC beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for ALC
Insider filing activity
ALC insiders filed 0 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
ALC news
- Alcon (SWX:ALC) The Latest Update Raises A Bigger QuestionOct 30, 2026 · finance.yahoo.com
- Glaukos Soars 26% on “Exceptional” Quarter and $1 Billion 2027 Sales OutlookOct 29, 2026 · tikr.com
- Alcon: Keeping An Eye Out Here Amid Sales And Margin MomentumOct 26, 2026 · seekingalpha.com
- Alcon's Neurotech Acquisition Offers Significant Growth Potential, Needham SaysOct 21, 2026 · finance.yahoo.com
- Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2Oct 20, 2026 · finance.yahoo.com
About Alcon Inc.
Alcon Inc. (ALC) is a US-listed public company on NYSE. The SEC classifies its business as Ophthalmic Goods. It is incorporated in Switzerland. Its fiscal year ends in December.